JAMA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
JAMA
Jul 16, 2024, 23:34 |
Blog
Integrating Clinical Trials and Practice - A New JAMA Series and Call for Papers
JAMA shared a post on X: ''JAMA invites articles for new article series, 'Integrating Clinical…
Jul 15, 2024, 08:33 |
Insight
Vivek Subbiah: ASCO24 Highlights from the JAMA Network
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jul 13, 2024, 12:13 |
Insight
Vivek Subbiah: Great JAMA weekend read on highlights from ASCO24
Vivek Subbiah shared on LinkedIn: "Happy Friday, World! Hot off the press - published in…
Jun 19, 2024, 14:22 |
Insight
Zhi Ven Fong: Our study as June’s Feature article in Annals of Surgery
Zhi Ven Fong, Pancreas and Liver surgeon at Mayo Clinic, shared on X: “Grateful to…
Jun 14, 2024, 14:42 |
Insight
USPSTF recommends all women undergo routine breast cancer screening every other year beginning at age 40 - JAMA Oncology
JAMA Oncology shared on X/Twitter: "From JAMA: USPSTF recommends all women undergo routine breast cancer…
Jun 14, 2024, 13:40 |
Insight
Arif Kamal: Which cancer patients should get palliative care?
Arif Kamal, Chief Patient Officer at American Cancer Society, shared a post on LinkedIn: “Which…
May 23, 2024, 10:36 |
Insight
Erman Akkus: Is patient participation in cancer drug trials associated with longer survival compared with routine care?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Is patient participation…
May 22, 2024, 09:36 |
Blog
Marco Donia: Does participation in Cancer Clinical Trials improve survival outcomes on its own?
Marco Donia, made the following post on LinkedIn: "Does participation in Cancer Clinical Trials improve survival…
May 5, 2024, 23:26 |
Blog
Mariana Socal: Global production of APIs experiencing US drug shortages
Mariana Socal, Associate Professor Johns Hopkins Bloomberg School of Public Health, made the following post…
May 5, 2024, 07:24 |
Blog
Robert Miller on aspirin to reduce the risk of recurrence
Robert Miller, Chief Medical Science Officer at CancerLinQ shared on LinkedIn: “When I was in…
Apr 18, 2024, 11:42 |
Blog
Aakash Desai: Our patient focused work discussing the complexities of clinical trials and what they mean in cancer care!
Aakash Desai, Assistant Professor at O'Neal Comprehensive Cancer Center at UAB, shared a post on LinkedIn: …
Apr 16, 2024, 10:57 |
Insight
Erman Akkus: 2 studies from JAMA and Thyroid Journal
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: 1.'' Second primary breast cancer…
Apr 14, 2024, 15:19 |
Blog
Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs
Eddie Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared a post on X: "Delighted to present…
Apr 12, 2024, 11:31 |
Blog
Scott Gottlieb: I had the opportunity to discuss the accelerated approval of cancer drugs on CNBC and share insights from a recent JAMA study
Scott Gottlieb, Partner at New Enterprise Associates, shared on LinkedIn: "Today, I had the opportunity to…
Apr 12, 2024, 09:11 |
Opinion
Piotr J. Wysocki: PSA screening does reduce prostate cancer mortality, but the overall benefit is small, according to a secondary analysis of the CAP trial
Piotr J. Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared a post…
Apr 11, 2024, 15:12 |
Insight
Erman Akkus: Prostate cancer screening: 2 studies of JAMA
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: ''Prostate cancer screening: 2…
Apr 7, 2024, 11:53 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemo is not given?
Roberto Leon-Ferre, Assistant Professor at Mayo Clinic, shared on X/Twitter: "What is the role of…
Apr 5, 2024, 16:38 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemotherapy is not given
Roberto Leon-Ferre, Medical Oncologist at Mayo Clinic, shared on their X/Twitter: ''What is the role…
Mar 3, 2024, 17:26 |
Insight
Anjali Sibley: Let’s Harness the Healing Power - The Benefits of Exercise and Physical Activity During Cancer Treatment
Anjali Sibley, Clinical Associate Professor of Medicine at Stanford University School of Medicine, shared a…
Feb 17, 2024, 17:47 |
Insight
Vivek Subbiah: Delighted to share Modernize Precision Oncology With Decentralized Trial Tools
Vivek Subbiah shared a post on X: "Hot off the press JAMA Oncology: Delighted to…
Feb 2, 2024, 12:51 |
Career
Kimmie Ng: So excited to serve as Associate Editor at JAMA
Kimmie Ng, Associate Chief of the Division of Gastrointestinal Oncology at Dana- Farber Cancer Institute,…
Jan 18, 2024, 15:43 |
Blog
Vinay Prasad: A balanced perspective on a new safety alert
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Jan 11, 2024, 07:34 |
Positive
Matteo Lambertini: Our study on pregnancy after breast cancer in young BRCA carriers
Matteo Lambertini, Associate Professor at the University of Genova, tweeted: "Our study on pregnancy after Breast…
Dec 29, 2023, 05:08 |
Blog
Vivek Subbiah: 1 in 3 academic physicians report they are considering leaving their institution within 2 years
Vivek Subbiah shared a post on X/Twitter: ''1 in 3 academic physicians report they are…
Dec 20, 2023, 10:50 |
Blog
Vinay Prasad: About a wild drug approval
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 17, 2023, 17:26 |
Blog
25 Posts Not To Miss From SABCS 2023
The San Antonio Breast Cancer Symposium 2023 (SABCS 2023) took place in San Antonio, Texas…
Dec 10, 2023, 16:53 |
Positive
Matteo Lambertini: December 7, 2023 …a day to remember
Matteo Lambertini, Associate Professor at the University of Genova, shared on LinkedIn: "December 7, 2023…
Nov 22, 2023, 02:38 |
Blog
Vivek Subbiah: When JAMA publishes a phase 1 study, it will be a practice-changing study in the future- Lepodisiran
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…
Aug 13, 2023, 23:42 |
Blog
Aurélie Degeneffe: Women with meningioma have a higher lifetime risk of breast cancer compared to the general female population
Quoting Aurélie Degeneffe, a neurosurgeon from the UZ Brussels, "A recent meta-analysis published in JAMA…
Jul 1, 2023, 13:35 |
Blog
Cancer is the leading cause of death among the US Hispanic population - Bella Pompa
Check out our most recent article from the Sophia Kamran lab published today in JAMA Oncology! Although…
Jun 16, 2023, 19:17 |
Blog
Today, we were listed as the authors of 3 most read research papers in JAMA this week - Reshma Jagsi
In 1995, Allison Walsh Allison Kurian, Rosovsky Rachel and I matriculated to med school together…
Jun 12, 2023, 03:23 |
Blog
Cancer care among refugees needs shared responsibility & global coordination - M. Tezer Kutluk
Our work “Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.” was published…
All:
32
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube